Cargando…
The Ocular Gene Delivery Landscape
The eye is at the forefront of developing therapies for genetic diseases. With the FDA approval of the first gene-therapy drug for a form of congenital blindness, numerous studies have been initiated to develop gene therapies for other forms of eye diseases. These examinations have revealed new info...
Autores principales: | Sahu, Bhubanananda, Chug, Isha, Khanna, Hemant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394578/ https://www.ncbi.nlm.nih.gov/pubmed/34439800 http://dx.doi.org/10.3390/biom11081135 |
Ejemplares similares
-
Oxidative Stress Resistance 1 Gene Therapy Retards Neurodegeneration in the rd1 Mutant Mouse Model of Retinopathy
por: Sahu, Bhubanananda, et al.
Publicado: (2021) -
Retinol Dehydrogenases Regulate Vitamin A Metabolism for Visual Function
por: Sahu, Bhubanananda, et al.
Publicado: (2016) -
Lipid Nanoparticles for Ocular Gene Delivery
por: Wang, Yuhong, et al.
Publicado: (2015) -
Presence of rd8 mutation does not alter the ocular phenotype of late-onset retinal degeneration mouse model
por: Sahu, Bhubanananda, et al.
Publicado: (2015) -
Ocular Barriers and Their Influence on Gene Therapy Products Delivery
por: Leclercq, Bastien, et al.
Publicado: (2022)